Suppr超能文献

无症状透析性低血压后心脏肌钙蛋白 I 升高:一项为期 2 年随访的初步研究。

Elevated Cardiac Troponin I following Asymptomatic Intradialytic Hypotension: A Pilot Study with a 2-Year Follow-Up.

机构信息

Clinical Research Development Unit of Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Int J Clin Pract. 2022 Aug 1;2022:4214429. doi: 10.1155/2022/4214429. eCollection 2022.

Abstract

BACKGROUND

Intradialytic hypotension (IDH) has been recognized as a serious and frequent complication during hemodialysis (HD) of end-stage renal disease (ESRD) patients, but the effect of asymptomatic IDH on cardiac troponin I (cTnI) levels is not definitively elucidated.

METHODS

70 asymptomatic HD patients with negative predialysis cTnI were included. They were on maintenance HD thrice weekly. All patients were monitored during the HD session for hemodynamic changes and symptoms related to IDH. Patients were followed for two years, and their outcomes are noted as an acute coronary syndrome (ACS), cardiac death, no ACS, noncardiac death, and kidney transplant.

RESULTS

Compared with the baseline blood pressure values, there was a drop in systolic blood pressure for all subjects, but according to the 2007 European Best Practice Guidelines on hemodynamic instability, asymptomatic IDH was defined in 27 (38.6%) patients. The results demonstrated a significant correlation ( = 0.492) ( < 0.05) between asymptomatic IDH and elevated postdialysis levels of cTnI. In 2-year follow-up of patients, ACS and cardiac death happened more in patients with elevated cTnI.

CONCLUSION

The results of our study suggest that asymptomatic IDH affects cTnI levels. Given that cTnI is a marker of myocardial damage and a predictor of cardiovascular mortality in ESRD patients, these findings recommend that considering the asymptomatic decrease in blood pressure levels during HD is very important and critical.

摘要

背景

透析中低血压(IDH)已被认为是终末期肾病(ESRD)患者血液透析(HD)过程中一种严重且频繁发生的并发症,但无症状 IDH 对心肌肌钙蛋白 I(cTnI)水平的影响尚未明确。

方法

纳入 70 例无症状且透析前 cTnI 为阴性的 HD 患者,他们每周接受 3 次维持性 HD。所有患者在 HD 过程中均监测血流动力学变化和与 IDH 相关的症状。患者随访 2 年,记录其结局为急性冠脉综合征(ACS)、心脏死亡、无 ACS、非心脏死亡和肾移植。

结果

与基线血压值相比,所有患者的收缩压均有所下降,但根据 2007 年欧洲最佳实践指南中关于血流动力学不稳定的定义,27 例(38.6%)患者被诊断为无症状 IDH。结果显示,无症状 IDH 与透析后 cTnI 水平升高之间存在显著相关性( = 0.492)( < 0.05)。在对患者 2 年的随访中,cTnI 升高的患者发生 ACS 和心脏死亡的情况更多。

结论

本研究结果表明,无症状 IDH 会影响 cTnI 水平。鉴于 cTnI 是 ESRD 患者心肌损伤的标志物和心血管死亡率的预测因子,这些发现表明,在 HD 期间考虑无症状血压下降非常重要且关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c900/9359825/ac4f9b5e2f4c/IJCLP2022-4214429.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验